CRIS : Summary for Curis, Inc. - Yahoo Finance

U.S. Markets close in 2 hrs 16 mins

Curis, Inc. (CRIS)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.44-0.09 (-3.56%)
As of 1:43PM EST. Market open.
People also watch
ARQLCERSAGENCYTRARRY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.53
Open2.51
Bid2.42 x 10100
Ask2.43 x 1400
Day's Range2.40 - 2.56
52 Week Range1.34 - 3.72
Volume265,940
Avg. Volume524,981
Market Cap342.94M
Beta2.68
PE Ratio (TTM)-5.06
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire6 days ago

    Curis to Present at the 2017 RBC Capital Markets Global Healthcare Conference

    LEXINGTON, Mass., Feb. 17, 2017-- Curis, Inc., a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of human cancers, today announced ...

  • 3 Top Stocks Under $5
    Motley Foollast month

    3 Top Stocks Under $5

    Cheap stocks are often cheap for a reason, but sometimes the market has mispriced their potential.

  • Curis, Inc. – Value Analysis (NASDAQ:CRIS) : January 13, 2017
    Capital Cubelast month

    Curis, Inc. – Value Analysis (NASDAQ:CRIS) : January 13, 2017

    Categories: Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives Curis, Inc. a score of 25. Our analysis is based on comparing Curis, Inc. with the following peers – Exelixis, Inc., Infinity Pharmaceuticals, Inc., Emergent BioSolutions Inc., Bristol-Myers Squibb Company, Spectrum Pharmaceuticals, Inc., Tetralogic Pharmaceuticals Corporation, Celldex Therapeutics, Inc., Pfizer Inc., Celgene Corporation and Madrigal Pharmaceuticals, Inc. ... Read more (Read more...)